Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 6, 2014, Pages 896-899

  Rueff, Jessica ^a   Medinger, Michael ^a   Heim, Dominik ^a   Passweg, Jakob ^a   Stern, Martin ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Autologous stem cell transplantation; Natural killer cells; Plasma cell myeloma

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CANCER PATIENT; CANCER RECURRENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NATURAL KILLER CELL; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; AUTOTRANSPLANTATION; BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; PATHOLOGY; PROCEDURES;

ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84899989272     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.03.007     Document Type: Article

References (23)

1. Savani B.N., Mielke S., Rezvani K., et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13:1216-1223.
2. Powles R., Singhal S., Treleaven J., et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 1998, 91:3481-3486.
3. Kim D.H., Kim J.G., Sohn S.K., et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 2004, 125:217-224.
4. Le Blanc K., Barrett A.J., Schaffer M., et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant 2009, 15:1108-1115.
5. Savani B.N., Mielke S., Adams S., et al. Rapid natural killer cell recovery determines outcome after T cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 2007, 21:2145-2152.
6. Joao C., Porrata L.F., Inwards D.J., et al. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma. Bone Marrow Transplant 2006, 37:865-871.
7. Yoong Y., Porrata L.F., Inwards D.J., et al. The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma. Leuk Lymphoma 2005, 46:1287-1294.
8. Kim H., Sohn H.J., Kim S., et al. Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant 2006, 37:1037-1042.
9. Porrata L.F., Gertz M.A., Inwards D.J., et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 2001, 98:579-585.
10. El-Sherbiny Y.M., Meade J.L., Holmes T.D., et al. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res 2007, 67:8444-8449.
11. Swift B.E., Williams B.A., Kosaka Y., et al. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. Haematologica 2012, 97:1020-1028.
12. Lambert C., Cristina I., Christian G. Enumeration of peripheral lymphocyte subsets using 6 vs. 4 color staining: a clinical evaluation of a new flowcytometer. Cytometry B Clin Cytom 2006, 70:29-38.
13. Durie B.G., Harousseau J.L., Miguel J.S., et al. International uniform response criteria for multiple myeloma. Leukemia 2006, 20:1467-1473.
14. Kim H., Sohn H.J., Kim S.E., et al. Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 2004, 34:43-49.
15. Porrata L.F., Litzow M.R., Tefferi A., et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002, 16:1311-1318.
16. Porrata L.F., Markovic S.N. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med 2004, 4:78-85.
17. Savani B.N., Rezvani K., Mielke S., et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2006, 107:1688-1695.
18. Jiang Y.Z., Barrett A.J., Goldman J.M., Mavroudis D.A. Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplant. Ann Hematol 1997, 74:1-6.
19. Sconocchia G., del Principe D., Barrett A.J. Non-classical antileukemia activity of early recovering NK cells after induction chemotherapy and HLA-identical stem cell transplantation in myeloid leukemias. Leukemia 2006, 20:1632-1633.
20. Hiwase D.K., Hiwase S., Bailey M., et al. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior OS following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2008, 14:116-124.
21. Shilling H.G., McQueen K.L., Cheng N.W., et al. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003, 101:3730-3740.
22. Vago L., Forno B., Sormani M.P., et al. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. Blood 2008, 112:3488-3499.
23. Alpdogan O., Eng J.M., Muriglan S.J., et al. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 2005, 105:865-873.